
|Articles|June 16, 2003
Time for transparency in drug pricing
A guest commentary on why average manufacturer prices and best prices should see the light of day.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves XFG-Targeted COVID-19 Vaccines From Multiple Companies
2
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
3
FDA Approves Stelara for Pediatric Ulcerative Colitis
4
COVID-19 in 2026: Why the Virus Still Threatens Vulnerable Patients
5




























